Biomedical Engineering Reference
In-Depth Information
Epithelial cancer stem cells can be isolated.
Cancer signaling pathways can be identified.
Selective agents that block cancer signaling pathways are being identified.
Delivery mechanisms for blocking agents need to be developed.
References
Adami GA. The Principles of Pathology. Henry Frowde, London, 1909.
Adams JM, Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant
clones? Cancer Res 2008;68:4018-4021.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MR. Prospective identi-
fication of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:
3983-3988.
Arnold I, Watt FM. c-Myc activation in transgenic mouse epidermis results in mobilization of
stem cells and differentiation of their progeny. Curr Biol 2001;1:558-568.
Aterman KJ. The stem cells of
the liver - a selective review. Cancer Clin Oncol
1992;118:87-115.
Bainbridge WS. The Cancer Problem. Macmillan, New York, 1914.
Baird SM. Hepatopoietic stem cells in leukemia and lymphoma. In Sell S (Ed) Stem Cells
Handbook. Humana Press, Totowa, NJ, 2004, pp 163-175.
Bannasch P. Sequential cellular changes during chemical carcinogenesis. J Cancer Res Clin
Oncol 1984;108:11-22.
Becker AJ, McCulloch E, Till J. Cytological demonstration of the clonal nature of spleen
colonies derived from transplanted mouse marrow cells. Nature 1963;197:452.
Benecke BW. Zeigler's Beitruge zur Path. Anat., 1892-1893.
Berenblum I. The mechanism of carcinogenesis. A study of the significance of cocarcinogenic
action and related phenomena. Cancer Res 1941;1:807. AN AACR SCIENTIFIC
LANDMARK.
Berenblum I. Carcinogenesis and tumor pathogenesis. Adv Cancer Res 1954;2:129-175.
Berenblum I, Shubik P. A new quantitative approach to the study of the stages of chemical
carcinogenesis in the mouse's skin. Br J Cancer 1947;1:384-391.
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates
from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
Borrel A. Le probleme du cancer. Bull Inst Pasteur 1907;5:497-512, 545, 593-608, 642-662.
Boutwell RK. Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res
1964;4:207-250.
Boveri R. Zur frage der entstehung maligner tumoren. Fischer, Jena, 1914. AN AACR
SCIENTIFIC LANDMARK.
Brown K, Strathdee D, Bryson S, Lambie W, Balmain A. The malignant capacity of skin
tumours induced by expression of a mutant H-ras transgene depends on the cell type
targeted. Curr Biol 1998;8:516-514.
Buick RN. In vitro clonogenicity of primary human tumor cells: quantitation and relationship
to tumor stem cells. In Salmon S (Ed) Cloning of Humor Tumor StemCells. AR Liss, New
York, 1980, pp 15-20, Chapter 2.
Camacho LY. Clinical application of retinoids in cancer medicine. J Biol Regul Homeost
Agents 2003:17:98-114.
Chalandon Y, Schwaller J. Targeting mutated protein tyrosine kinases and their signaling
pathways in hematologic malignancies. Haematologica 2005;90:949-968.
Chan DW, Sell S. Tumor markers. In Burtis CA, Ashwood ER (Eds) Tietez Textbook of
Clinical Chemistry, 5nd Edn. Saunders, Philadelphia, 2001, pp 390-413.
